JPRN-UMIN000035527已完成未知
anthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia - Lanthanum Versus Calcium Carbonate for Patients With CKD
Department of Nephrology, Osaka University Hospital0 个研究点目标入组 60 人开始时间: 2019年1月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) History of cardiac surgery and/or coronary artery stenting (2) Polycystic kidney disease (3) Hypothyroidism (4) On treatment with lanthanum carbonate (5) History of admission within 3 months (6) History of ileus (7) Severe gastrointestinal dysfunction (8) Severe liver dysfunction (9) Allergy to lanthanum carbonate or calcium carbonate (10) Pregnant or breastfeeding women (11) Judged as ineligible by primary physicians
研究者
相似试验
已完成
不适用
anthanum Versus Calcium Carbonate for Patients With CKDnon-dialysis chronic kidney diseaseJPRN-jRCTs051180055Sakaguchi Yusuke40
已完成
4 期
anthanum carbonate impacts on calcification regulating factors in chronic kidney diseaseJPRN-UMIN000013978Department of Medicine, Kidney Center, Tokyo Women's Medical University60
已完成
不适用
Vascular Calcification does not predict anastomotic leak or conduit necrosis following oesophagectomy for malignancy in a UK cohortC15.9Oesophagus, unspecifiedDRKS00016750niversity of Birmingham413
招募中
不适用
Bixalomer versus calcium carbonate on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a randomized study.endstage kidney disease on hemodialysisJPRN-UMIN000013147CKD-MBD Clinical Study Group300
已完成
3 期
Evaluation of vascular calcification in relation to biomarker and vitminK in hemodialysis patientsChronic renal failureJPRN-UMIN000011490Fujita Health University School of Medicine, Department of Nephrology207